{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:41Z","timestamp":1790655101998,"version":"4.1.0"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b17-00291","type":"journal-article","created":{"date-parts":[[2017,9,30]],"date-time":"2017-09-30T22:17:16Z","timestamp":1506809836000},"page":"1716-1723","source":"Crossref","is-referenced-by-count":9,"title":["The Aldosterone Receptor Antagonist Eplerenone Inhibits Isoproterenol-Induced Collagen-I and 11\u03b2-HSD1 Expression in Rat Cardiac Fibroblasts and the Left Ventricle"],"prefix":"10.1248","volume":"40","author":[{"given":"Yasutomo","family":"Hori","sequence":"first","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Touei","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Kanai","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Hoshi","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Itoh","sequence":"additional","affiliation":[{"name":"Laboratory of Small Animal Internal Medicine, School of Veterinary Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Brum PC, Rolim NP, Bacurau AV, Medeiros A. Neurohumoral activation in heart failure: the role of adrenergic receptors. An. Acad. Bras. Cienc.<\/i>, 78<\/b>, 485\u2013503 (2006)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol.<\/i>, 54<\/b>, 375\u2013385 (2009).","DOI":"10.1016\/j.jacc.2009.03.061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation<\/i>, 82<\/b>, 1730\u20131736 (1990).","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hori Y, Yoshioka K, Kanai K, Hoshi F, Itoh N, Higuchi S-I. Spironolactone decreases isoproterenol-induced ventricular fibrosis and matrix metalloproteinase-2 in rats. Biol. Pharm. Bull.<\/i>, 34<\/b>, 61\u201365 (2011).","DOI":"10.1248\/bpb.34.61"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, Funder JW, McMahon EG. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ. Res.<\/i>, 93<\/b>, 69\u201376 (2003).","DOI":"10.1161\/01.RES.0000080521.15238.E5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Veliotes DG, Woodiwiss AJ, Deftereos DA, Gray D, Osadchii O, Norton GR. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension<\/i>, 45<\/b>, 914\u2013920 (2005).","DOI":"10.1161\/01.HYP.0000164567.62172.c5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ, Lopez-Novoa JM, Bustelo XR. Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat. Med.<\/i>, 12<\/b>, 841\u2013845 (2006).","DOI":"10.1038\/nm1426"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) De L\u00e9an A, Racz K, McNicoll N, Desrosiers ML. Direct beta-adrenergic stimulation of aldosterone secretion in cultured bovine adrenal subcapsular cells. Endocrinology<\/i>, 115<\/b>, 485\u2013492 (1984).","DOI":"10.1210\/endo-115-2-485"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pratt JH, Turner DA, McAteer JA, Henry DP. beta-Adrenergic stimulation of aldosterone production by rat adrenal capsular explants. Endocrinology<\/i>, 117<\/b>, 1189\u20131194 (1985).","DOI":"10.1210\/endo-117-3-1189"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Bos R, Mougenot N, Mediani O, Vanhoutte PM, Lechat P. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat. J. Pharmacol. Exp. Ther.<\/i>, 309<\/b>, 1160\u20131166 (2004).","DOI":"10.1124\/jpet.103.063388"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gallego M, Espina L, Vegas L, Echevarria E, Iriarte MM, Casis O. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats. Pharmacol. Res.<\/i>, 44<\/b>, 311\u2013315 (2001).","DOI":"10.1006\/phrs.2001.0865"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rogerson FM, Yao Y, Smith BJ, Fuller PJ. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor. Clin. Exp. Pharmacol. Physiol.<\/i>, 31<\/b>, 704\u2013709 (2004).","DOI":"10.1111\/j.1440-1681.2004.04079.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Enomoto S, Yoshiyama M, Omura T, Matsumoto R, Kusuyama T, Kim S, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction. Heart<\/i>, 91<\/b>, 1595\u20131600 (2005).","DOI":"10.1136\/hrt.2004.046540"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. J. Am. Coll. Cardiol.<\/i>, 42<\/b>, 1666\u20131673 (2003).","DOI":"10.1016\/j.jacc.2003.05.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, Matsuoka H. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension<\/i>, 47<\/b>, 671\u2013679 (2006).","DOI":"10.1161\/01.HYP.0000203148.42892.7a"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kuster GM, Kotlyar E, Rude MK, Siwik DA, Liao R, Colucci WS, Sam F. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation<\/i>, 111<\/b>, 420\u2013427 (2005).","DOI":"10.1161\/01.CIR.0000153800.09920.40"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A. Aldosterone stimulates collagen gene expression and synthesis via<\/i> activation of ERK1\/2 in rat renal fibroblasts. Hypertension<\/i>, 46<\/b>, 1039\u20131045 (2005).","DOI":"10.1161\/01.HYP.0000174593.88899.68"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Susic D, Varagic J, Ahn J, Matavelli L, Frohlich ED. Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Am. J. Physiol. Heart Circ. Physiol.<\/i>, 292<\/b>, H175\u2013H179 (2007).","DOI":"10.1152\/ajpheart.00660.2006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Okamoto M, Nonaka Y, Takemori H, Doi J. Molecular identity and gene expression of aldosterone synthase cytochrome P450. Biochem. Biophys. Res. Commun.<\/i>, 338<\/b>, 325\u2013330 (2005).","DOI":"10.1016\/j.bbrc.2005.07.187"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension<\/i>, 47<\/b>, 656\u2013664 (2006).","DOI":"10.1161\/01.HYP.0000203772.78696.67"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ye P, Kenyon CJ, MacKenzie SM, Jong AS, Miller C, Gray GA, Wallace A, Ryding AS, Mullins JJ, McBride MW, Graham D, Fraser R, Connell JM, Davies E. The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart. Endocrinology<\/i>, 146<\/b>, 5287\u20135293 (2005).","DOI":"10.1210\/en.2005-0370"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Leicht M, Greipel N, Zimmer H. Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc. Res.<\/i>, 48<\/b>, 274\u2013284 (2000).","DOI":"10.1016\/S0008-6363(00)00170-X"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Golomb E, Abassi ZA, Cuda G, Stylianou M, Panchal VR, Trachewsky D, Keiser HR. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am. J. Physiol.<\/i>, 267<\/b>, H1496\u2013H1506 (1994).","DOI":"10.1152\/ajpheart.1994.267.4.H1496"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Fraccarollo D, Galuppo P, Schraut S, Kneitz S, van Rooijen N, Ertl G, Bauersachs J. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension<\/i>, 51<\/b>, 905\u2013914 (2008).","DOI":"10.1161\/HYPERTENSIONAHA.107.100941"},{"key":"25","unstructured":"25) Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol.<\/i>, 26<\/b>, 809\u2013820 (1994)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol. Cell. Biochem.<\/i>, 154<\/b>, 171\u2013178 (1996).","DOI":"10.1007\/BF00226785"},{"key":"27","unstructured":"27) Leenen FH, White R, Yuan B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus<\/i> cardiac renin\u2013angiotensin system. Am. J. Physiol. Heart Circ. Physiol.<\/i>, 281<\/b>, H2410\u2013H2416 (2001)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ferreira JC, Bacurau AV, Evangelista FS, Coelho MA, Oliveira EM, Casarini DE, Krieger JE, Brum PC. The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, 294<\/b>, R26\u2013R32 (2008).","DOI":"10.1152\/ajpregu.00424.2007"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ito T, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, Harada E, Mizuno Y, Yamamuro M, Harada M, Saito Y, Nakao K, Kurihara H, Yasue H, Ogawa H. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation<\/i>, 107<\/b>, 807\u2013810 (2003).","DOI":"10.1161\/01.CIR.0000057794.29667.08"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Smith RE, Krozowski ZS. 11beta-Hydroxysteroid dehydrogenase type I enzyme in the hearts of normotensive and spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol.<\/i>, 23<\/b>, 642\u2013647 (1996).","DOI":"10.1111\/j.1440-1681.1996.tb01750.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) White CI, Jansen MA, McGregor K, Mylonas KJ, Richardson RV, Thomson A, Moran CM, Seckl JR, Walker BR, Chapman KE, Gray GA. Cardiomyocyte and vascular smooth muscle-independent 11beta-hydroxysteroid dehydrogenase 1 amplifies infarct expansion, hypertrophy, and the development of heart failure after myocardial infarction in male mice. Endocrinology<\/i>, 157<\/b>, 346\u2013357 (2016).","DOI":"10.1210\/en.2015-1630"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Rickard AJ, Funder JW, Fuller PJ, Young MJ. The role of the glucocorticoid receptor in mineralocorticoid\/salt-mediated cardiac fibrosis. Endocrinology<\/i>, 147<\/b>, 5901\u20135906 (2006).","DOI":"10.1210\/en.2006-0658"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Rude MK, Duhaney TA, Kuster GM, Judge S, Heo J, Colucci WS, Siwik DA, Sam F. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes. Hypertension<\/i>, 46<\/b>, 555\u2013561 (2005).","DOI":"10.1161\/01.HYP.0000176236.55322.18"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kim J, Eckhart AD, Eguchi S, Koch WJ. beta-Adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J. Biol. Chem.<\/i>, 277<\/b>, 32116\u201332123 (2002).","DOI":"10.1074\/jbc.M204895200"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Murray DR, Mummidi S, Valente AJ, Yoshida T, Somanna NK, Delafontaine P, Dinarello CA, Chandrasekar B. \u03b22 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro<\/i> and myocardial hypertrophy in vivo.<\/i> J. Mol. Cell. Cardiol.<\/i>, 52<\/b>, 206\u2013218 (2012).","DOI":"10.1016\/j.yjmcc.2011.09.022"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, Nakamura E, Yoshizumi M, Shokoji T, Kimura S, Kiyomoto H, Tsujioka K, Kohno M, Tamaki T, Kajiya F, Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension<\/i>, 45<\/b>, 710\u2013716 (2005).","DOI":"10.1161\/01.HYP.0000154681.38944.9a"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Hypertens. Res.<\/i>, 30<\/b>, 427\u2013437 (2007).","DOI":"10.1291\/hypres.30.427"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/10\/40_b17-00291\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T04:28:32Z","timestamp":1570163312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/10\/40_b17-00291\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00291","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}